Pharmaceutical consultation, research and development services, namely, identifying alternative indications, doses, or patient populations for a compound that has failed, stalled or been deprioritized so it can be redirected back into clinical development.
Pharmaceutical consultation, research and development services, namely, identifying alternative indications, doses, or patient populations for a compound that has failed, stalled or been deprioritized so it can be redirected back into clinical development.
Pharmaceutical consultation, research and development services, namely...
